CWChristopher D. Witiw

Christopher D. Witiw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher D. Witiw has a total of 202 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endoscopic Versus Open Microdiscectomy for Lumbar Disc Herniation: A Cost-Utility Analysis Using a Lifetime Markov Model

    by Jasleen Saini, Paul Tieu, Christopher Lozano, Vishwathsen Karthikeyan, Husain Shakil, Armaan K. Malhotra, Yingshi He, Saira B. Alli, Douglas Lee, Jefferson R. Wilson, et al.

    Objective: To evaluate the lifetime cost-utility of endoscopic microdiscectomy (EM) compared with open microdiscectomy (OM) for the surgical treatment of symptomatic lumbar disc herniation (LDH) from a Canadian healthcare payer perspective. Methods: A three-state Markov state-transition model (responder, non-responder, death) with annual cycles simulated a hypothetical cohort of adults undergoing EM or OM over a lifetime horizon. Costs and quality-adjusted life years (QALYs) were discounted at 1.5% annually. Transition probabilities, utilities and costs were derived from randomized controlled trials, systematic reviews and published economic data. Cost-effectiveness was assessed using incremental cost-effectiveness ratios (ICERs) and net monetary benefit (NMB) at a willingness-to-pay threshold of $50,000 per QALY. Deterministic and probabilistic sensitivity analyses, including 1,000 Monte Carlo simulations, were performed to evaluate parameter uncertainty and model robustness. Results: In the base-case analysis, lifetime costs were $11,144 for OM and $11,162 for EM, with discounted QALYs of 24.55 and 24.59, respectively. EM yielded an incremental gain of 0.042 QALYs at an additional cost of $18, corresponding to an ICER of $434 per QALY. At a willingness-to-pay threshold of $50,000 per QALY, EM demonstrated a modestly higher NMB. Probabilistic sensitivity analysis showed substantial overlap between strategies, with EM favored in 55.2% of simulations. Conclusions: EM and OM provide comparable lifetime health outcomes and economic value. Although EM showed a small base-case advantage, this difference was not robust to uncertainty. These findings should be interpreted in the context of local implementation factors, including endoscopic equipment costs and health system structure, which may influence real-world adoption.

  • Predicting Return Home After Moderate-to-Severe Traumatic Brain Injury

    by Armaan K. Malhotra, Avery B. Nathens, Husain Shakil, Vishwathsen Karthikeyan, Christopher S. Lozano, Jetan H. Badhiwala, Francois Mathieu, Benjamin Davidson, Yingshi He, Abhaya V. Kulkarni, et al.

    Days alive and at home (DAH) is a validated outcome measure that captures health care transitions between time spent at home vs various nonhome care settings, offering a more nuanced patient-centered understanding of recovery. We aimed to (1) characterize long-term recovery trajectories for adults with moderate-to-severe traumatic brain injury (msTBI) using DAH and (2) develop and internally validate a clinical prediction model for favorable vs unfavorable recovery. This multicenter retrospective population-based cohort study was performed in Ontario, Canada; we identified adults hospitalized with isolated msTBI between 2009 and 2021 that survived beyond 72 hours postadmission. DAH was calculated in 30-day intervals from index admission through 3 years postinjury. Latent class mixed modeling identified unique recovery trajectories. Sociodemographic, clinical, and injury variables were then evaluated as candidate predictors. Logistic regression, penalized regression, and machine learning approaches were compared for discrimination of favorable (early, intermediate, or late recovery) vs unfavorable (delayed deterioration or poor recovery) trajectories. Model performance was evaluated in a held-out test set using area under the receiver operating characteristic curve (AUC) with 95% CIs. There were 3,004 adults included in the cohort with an overall male predominance (n = 2,284, 76.1%), and the average age was 49.6 years (SD 21.4). Latent class mixed modeling revealed 5 distinct DAH trajectories: early recovery (38.6%), intermediate recovery (27.5%), and late recovery (3.2%) groups were characterized by return to the community at varying time intervals; by contrast, delayed deterioration (3.4%) and poor recovery (27.3%) groups experienced limited time at home at final follow-up. Patients in the unfavorable recovery trajectory groups were older, frailer, and more likely to sustain fall-related injuries. Radiographic predictors of poor outcome included subdural hematoma, large intraparenchymal hematoma, diffuse axonal injury, and cerebral edema. Using various demographic, injury and radiographic characteristics, a prediction model (DAH-TBI calculator) could discriminate trajectories with an AUC of 0.812 (95% CI 782-0.842) on a held-out internal validation data set. Our findings emphasize a longer period of postinjury outcome observation may be necessary to capture societal reintegration after msTBI. We developed and internally validated the DAH-TBI calculator to predict long-term postinjury outcomes.


  • Open Access

    Nonfatal self-injury in the first year after surgery: a population-based epidemiologic study

    by Calvin Diep, Julian F. Daza, Sandra Lee, Christopher Witiw, Simone Vigod, Duminda N. Wijeysundera, Karim S. Ladha


  • Trends and Impact of Pharmacological VTE Prophylaxis Timing for Traumatic Cervical Spinal Cord Injury Across North American Trauma Centers

    by Ahmad Essa, Armaan K. Malhotra, Husain Shakil, James P. Byrne, Jetan Badhiwala, Avery B. Nathens, Tej D. Azad, Eva Y. Yuan, Yingshi He, Andrew S. Jack, et al.

    Background: The aims of this study were to evaluate the timing and trend of venous thromboembolism (VTE) prophylaxis initiation following surgical intervention, and the impact of VTE prophylaxis timing on the occurrence of VTE complications, across North American trauma centers in patients with complete traumatic cervical spinal cord injury (SCI). Methods: This retrospective, observational cohort study utilized data from the American College of Surgeons (ACS) Trauma Quality Improvement Program (TQIP) from 2013 to 2020. We identified surgically treated patients with complete traumatic cervical SCI. Patient variables included age, sex, race, insurance coverage, and comorbidity status. Outcomes of interest included time to VTE prophylaxis following surgery and the occurrence of VTE complications. Mixed-effect regression models were constructed to evaluate the adjusted estimate for each outcome accounting for patient-, injury-, and hospital-level covariates. Results: The study included 5,325 patients treated across 463 trauma centers. The mean age in the cohort was 46.7 ± 18.9 years, with male predominance (81.1%). Race was predominantly White (62.3%) and Black (23.0%). The mean time to VTE prophylaxis initiation was 90 ± 112 hours, and the median time was 65 hours (interquartile range, 39 to 105 hours). The annual trend of VTE prophylaxis initiation after surgery was a decrease by 5.2 hours per year over the 8-year study interval. This was associated with an annual reduction of 6.2% in the odds of VTE complication occurrence. Multivariable mixed-effect regression models demonstrated a significant reduction in time to VTE prophylaxis (mean difference, −3.7 hours per year [95% confidence interval [CI], −5.3 to −2.1 hours per year]; p < 0.001) and VTE complications (odds ratio, 0.93 per year [95% CI, 0.88 to 0.98 per year]; p = 0.01) over the study period, after adjustment. Conclusions: This analysis provides insight into VTE prophylaxis practice patterns following surgery for complete cervical SCI across North American trauma centers from 2013 to 2020. The timing of VTE prophylaxis initiation consistently decreased, which appeared to be associated with a significant reduction found in VTE complications. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

  • Association of loneliness and social isolation with postoperative outcomes: a retrospective registry study

    by Kaylyssa Philip, Amber Jolly, Calvin Diep, Rachel D. Savage, Duminda N. Wijeysundera, Christopher Witiw, Karim S. Ladha


  • Open Access

    ARDS After Spinal Cord Injury

    by Christopher S. Lozano, Vishwathsen Karthikeyan, Michael C. Sklar, Ahmad Essa, Francois Mathieu, Husain Shakil, Armaan K. Malhotra, Vincent Ye, Alexandra De Sequeira, Andrew S. Jack, et al.


  • Energy Considerations for Scaling Artificial Intelligence Adoption in Medicine: First Do No Harm

    by Armaan K. Malhotra, Amol A. Verma, Christopher W. Smith, Husain Shakil, Muhammad Mamdani, Laura C. Rosella, Christopher D. Witiw, Jefferson R. Wilson


  • Association Between Myocardial Infarction and In-Hospital Complications in Cervical Spinal Cord Injury: A Retrospective Cohort Study

    by Vishwathsen Karthikeyan, Husain Shakil, Ambika Tejpal, Jetan H. Badhiwala, Martin Profant, Armaan K. Malhotra, Christopher S. Lozano, Ahmad Essa, Eva Y. Yuan, Yingshi He, et al.

    Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in individuals with spinal cord injury (SCI), with a particularly high burden in patients with upper cervical spine injuries. Outcomes of SCI in patients with chronic CVD have been the topic of extensive research, but the incidence and impact of myocardial infarction (MI) in the acute post-injury phase are not well established. In this study, we examined the incidence of MI in cervical SCI and its impact on in-hospital complications, mortality, and resource utilization. We conducted a retrospective cohort study using data from the American College of Surgeons Trauma Quality Improvement Program from 2010 to 2020, identifying adult patients (≥16 years) with cervical SCI. MI was identified based on ischemic electrocardiographic changes, troponin elevation greater than three times the upper limit of normal, and physician-documented diagnosis. Outcomes included in-hospital major adverse events, immobility-related adverse events, mortality, total length of stay (LOS), intensive care unit (ICU) LOS, and duration of mechanical ventilation. The association between the development of MI and outcomes in patients with cervical SCI was analyzed using multivariate regression analyses, adjusting for baseline covariates. A total of 39,030 patients with cervical SCI were included, of whom 161 (0.4%) had a history of MI. Patients with MI were older (67 ± 14 vs. 53 ± 19 years, p < 0.001) and had a higher prevalence of hypertension, diabetes, chronic kidney disease, chronic obstructive pulmonary disease, and congestive heart failure (all p < 0.05). MI was associated with significantly increased odds of major adverse events, including acute kidney injury (odds ratio [OR]: 7.2, 95% confidence interval [CI]: 4.4–11.3), acute respiratory distress syndrome (OR: 3.9, 95% CI: 2.2–6.5), cardiac arrest (OR: 5.4, 95% CI: 3.6–8.0), ventilator-associated pneumonia (OR: 3.9, 95% CI: 2.6–5.7), cerebrovascular accident (OR: 3.5, 95% CI: 1.4–7.2), sepsis (OR: 4.9, 95% CI: 2.7–8.1), and unplanned ICU admission (OR: 1.9, 95% CI: 1.1–3.1, all p < 0.05). MI was also associated with increased odds of pressure ulcers (OR: 2.8, 95% CI: 1.7–4.4, p < 0.001). Patients with MI had higher odds of mortality (OR: 3.9, 95% CI: 2.7–5.7, p < 0.001) and significantly prolonged hospital stays, with an increase of 8.5 days (95% CI: 6.0–10.9, p < 0.001) in total LOS, 7.3 days (95% CI: 5.5–9.1, p < 0.001) in ICU LOS, and 6.4 days (95% CI: 3.7–9.2, p < 0.001) on mechanical ventilation. MI in the acute phase of cervical SCI is rare but is associated with significantly worse in-hospital outcomes, prolonged ICU stays, and higher mortality. Given the heightened cardiovascular vulnerability in this population, early recognition and targeted management strategies are warranted to mitigate adverse outcomes.

  • Open Access

    Laminoplasty compared to laminectomy and fusion for degenerative cervical myelopathy: a cost-utility analysis

    by Christopher S Lozano, Vishwathsen Karthikeyan, Armaan K Malhotra, Husain Shakil, Abdullah Ishaque, Jasleen Saini, Yingshi He, Eva Y Yuan, Jetan H Badhiwala, Michael G Fehlings, et al.